nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—Dermatitis—Mometasone—systemic scleroderma	0.00084	0.00084	CcSEcCtD
Vigabatrin—Decreased appetite—Leflunomide—systemic scleroderma	0.000839	0.000839	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000839	0.000839	CcSEcCtD
Vigabatrin—Osteoarthritis—Methotrexate—systemic scleroderma	0.000838	0.000838	CcSEcCtD
Vigabatrin—Confusional state—Lisinopril—systemic scleroderma	0.000836	0.000836	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000836	0.000836	CcSEcCtD
Vigabatrin—Headache—Mometasone—systemic scleroderma	0.000835	0.000835	CcSEcCtD
Vigabatrin—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000834	0.000834	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000833	0.000833	CcSEcCtD
Vigabatrin—Insomnia—Mycophenolic acid—systemic scleroderma	0.000833	0.000833	CcSEcCtD
Vigabatrin—Fatigue—Leflunomide—systemic scleroderma	0.000832	0.000832	CcSEcCtD
Vigabatrin—Oedema—Lisinopril—systemic scleroderma	0.000829	0.000829	CcSEcCtD
Vigabatrin—Pruritus—Captopril—systemic scleroderma	0.000829	0.000829	CcSEcCtD
Vigabatrin—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000827	0.000827	CcSEcCtD
Vigabatrin—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000826	0.000826	CcSEcCtD
Vigabatrin—Pain—Leflunomide—systemic scleroderma	0.000825	0.000825	CcSEcCtD
Vigabatrin—Constipation—Leflunomide—systemic scleroderma	0.000825	0.000825	CcSEcCtD
Vigabatrin—Infection—Lisinopril—systemic scleroderma	0.000824	0.000824	CcSEcCtD
Vigabatrin—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000823	0.000823	CcSEcCtD
Vigabatrin—Somnolence—Mycophenolic acid—systemic scleroderma	0.000819	0.000819	CcSEcCtD
Vigabatrin—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000818	0.000818	CcSEcCtD
Vigabatrin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000814	0.000814	CcSEcCtD
Vigabatrin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000811	0.000811	CcSEcCtD
Vigabatrin—Body temperature increased—Azathioprine—systemic scleroderma	0.000808	0.000808	CcSEcCtD
Vigabatrin—Abdominal pain—Azathioprine—systemic scleroderma	0.000808	0.000808	CcSEcCtD
Vigabatrin—Skin disorder—Lisinopril—systemic scleroderma	0.000806	0.000806	CcSEcCtD
Vigabatrin—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000803	0.000803	CcSEcCtD
Vigabatrin—Diarrhoea—Captopril—systemic scleroderma	0.000801	0.000801	CcSEcCtD
Vigabatrin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.0008	0.0008	CcSEcCtD
Vigabatrin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.0008	0.0008	CcSEcCtD
Vigabatrin—Irritability—Methotrexate—systemic scleroderma	0.000799	0.000799	CcSEcCtD
Vigabatrin—Erectile dysfunction—Prednisone—systemic scleroderma	0.000798	0.000798	CcSEcCtD
Vigabatrin—Feeling abnormal—Leflunomide—systemic scleroderma	0.000795	0.000795	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000795	0.000795	CcSEcCtD
Vigabatrin—Fatigue—Mycophenolic acid—systemic scleroderma	0.000794	0.000794	CcSEcCtD
Vigabatrin—Mood swings—Methotrexate—systemic scleroderma	0.000793	0.000793	CcSEcCtD
Vigabatrin—Nausea—Mometasone—systemic scleroderma	0.000792	0.000792	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000789	0.000789	CcSEcCtD
Vigabatrin—Weight increased—Prednisone—systemic scleroderma	0.000788	0.000788	CcSEcCtD
Vigabatrin—Ataxia—Methotrexate—systemic scleroderma	0.000788	0.000788	CcSEcCtD
Vigabatrin—Pain—Mycophenolic acid—systemic scleroderma	0.000787	0.000787	CcSEcCtD
Vigabatrin—Constipation—Mycophenolic acid—systemic scleroderma	0.000787	0.000787	CcSEcCtD
Vigabatrin—Cough—Mycophenolate mofetil—systemic scleroderma	0.000777	0.000777	CcSEcCtD
Vigabatrin—Dizziness—Captopril—systemic scleroderma	0.000774	0.000774	CcSEcCtD
Vigabatrin—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000771	0.000771	CcSEcCtD
Vigabatrin—Depression—Prednisone—systemic scleroderma	0.00077	0.00077	CcSEcCtD
Vigabatrin—Urticaria—Leflunomide—systemic scleroderma	0.000767	0.000767	CcSEcCtD
Vigabatrin—Abdominal pain—Leflunomide—systemic scleroderma	0.000763	0.000763	CcSEcCtD
Vigabatrin—Body temperature increased—Leflunomide—systemic scleroderma	0.000763	0.000763	CcSEcCtD
Vigabatrin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000759	0.000759	CcSEcCtD
Vigabatrin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000758	0.000758	CcSEcCtD
Vigabatrin—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000758	0.000758	CcSEcCtD
Vigabatrin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000758	0.000758	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000757	0.000757	CcSEcCtD
Vigabatrin—Breast disorder—Methotrexate—systemic scleroderma	0.000757	0.000757	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000756	0.000756	CcSEcCtD
Vigabatrin—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000755	0.000755	CcSEcCtD
Vigabatrin—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000754	0.000754	CcSEcCtD
Vigabatrin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000753	0.000753	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000753	0.000753	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000753	0.000753	CcSEcCtD
Vigabatrin—Insomnia—Lisinopril—systemic scleroderma	0.00075	0.00075	CcSEcCtD
Vigabatrin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000749	0.000749	CcSEcCtD
Vigabatrin—Paraesthesia—Lisinopril—systemic scleroderma	0.000745	0.000745	CcSEcCtD
Vigabatrin—Vomiting—Captopril—systemic scleroderma	0.000745	0.000745	CcSEcCtD
Vigabatrin—Rash—Captopril—systemic scleroderma	0.000738	0.000738	CcSEcCtD
Vigabatrin—Dermatitis—Captopril—systemic scleroderma	0.000738	0.000738	CcSEcCtD
Vigabatrin—Somnolence—Lisinopril—systemic scleroderma	0.000737	0.000737	CcSEcCtD
Vigabatrin—Headache—Captopril—systemic scleroderma	0.000734	0.000734	CcSEcCtD
Vigabatrin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000733	0.000733	CcSEcCtD
Vigabatrin—Dyspepsia—Lisinopril—systemic scleroderma	0.00073	0.00073	CcSEcCtD
Vigabatrin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000728	0.000728	CcSEcCtD
Vigabatrin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000728	0.000728	CcSEcCtD
Vigabatrin—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000727	0.000727	CcSEcCtD
Vigabatrin—Infection—Mycophenolate mofetil—systemic scleroderma	0.000722	0.000722	CcSEcCtD
Vigabatrin—Decreased appetite—Lisinopril—systemic scleroderma	0.000721	0.000721	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000716	0.000716	CcSEcCtD
Vigabatrin—Fatigue—Lisinopril—systemic scleroderma	0.000715	0.000715	CcSEcCtD
Vigabatrin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000713	0.000713	CcSEcCtD
Vigabatrin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000711	0.000711	CcSEcCtD
Vigabatrin—Pain—Lisinopril—systemic scleroderma	0.000709	0.000709	CcSEcCtD
Vigabatrin—Constipation—Lisinopril—systemic scleroderma	0.000709	0.000709	CcSEcCtD
Vigabatrin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000706	0.000706	CcSEcCtD
Vigabatrin—Diarrhoea—Azathioprine—systemic scleroderma	0.000699	0.000699	CcSEcCtD
Vigabatrin—Nausea—Captopril—systemic scleroderma	0.000696	0.000696	CcSEcCtD
Vigabatrin—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000694	0.000694	CcSEcCtD
Vigabatrin—Asthenia—Leflunomide—systemic scleroderma	0.000693	0.000693	CcSEcCtD
Vigabatrin—Hallucination—Prednisone—systemic scleroderma	0.00069	0.00069	CcSEcCtD
Vigabatrin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000683	0.000683	CcSEcCtD
Vigabatrin—Pruritus—Leflunomide—systemic scleroderma	0.000683	0.000683	CcSEcCtD
Vigabatrin—Connective tissue disorder—Prednisone—systemic scleroderma	0.000681	0.000681	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000678	0.000678	CcSEcCtD
Vigabatrin—Dizziness—Azathioprine—systemic scleroderma	0.000676	0.000676	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000673	0.000673	CcSEcCtD
Vigabatrin—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000667	0.000667	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000662	0.000662	CcSEcCtD
Vigabatrin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000661	0.000661	CcSEcCtD
Vigabatrin—Diarrhoea—Leflunomide—systemic scleroderma	0.00066	0.00066	CcSEcCtD
Vigabatrin—Urticaria—Lisinopril—systemic scleroderma	0.000659	0.000659	CcSEcCtD
Vigabatrin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000657	0.000657	CcSEcCtD
Vigabatrin—Abdominal pain—Lisinopril—systemic scleroderma	0.000656	0.000656	CcSEcCtD
Vigabatrin—Body temperature increased—Lisinopril—systemic scleroderma	0.000656	0.000656	CcSEcCtD
Vigabatrin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000653	0.000653	CcSEcCtD
Vigabatrin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000651	0.000651	CcSEcCtD
Vigabatrin—Vomiting—Azathioprine—systemic scleroderma	0.00065	0.00065	CcSEcCtD
Vigabatrin—Pneumonia—Methotrexate—systemic scleroderma	0.000649	0.000649	CcSEcCtD
Vigabatrin—Eye disorder—Prednisone—systemic scleroderma	0.000648	0.000648	CcSEcCtD
Vigabatrin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000646	0.000646	CcSEcCtD
Vigabatrin—Infestation NOS—Methotrexate—systemic scleroderma	0.000645	0.000645	CcSEcCtD
Vigabatrin—Drowsiness—Methotrexate—systemic scleroderma	0.000645	0.000645	CcSEcCtD
Vigabatrin—Infestation—Methotrexate—systemic scleroderma	0.000645	0.000645	CcSEcCtD
Vigabatrin—Rash—Azathioprine—systemic scleroderma	0.000644	0.000644	CcSEcCtD
Vigabatrin—Dermatitis—Azathioprine—systemic scleroderma	0.000644	0.000644	CcSEcCtD
Vigabatrin—Depression—Methotrexate—systemic scleroderma	0.000644	0.000644	CcSEcCtD
Vigabatrin—Headache—Azathioprine—systemic scleroderma	0.00064	0.00064	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.00064	0.00064	CcSEcCtD
Vigabatrin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00064	0.00064	CcSEcCtD
Vigabatrin—Dizziness—Leflunomide—systemic scleroderma	0.000638	0.000638	CcSEcCtD
Vigabatrin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000632	0.000632	CcSEcCtD
Vigabatrin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00063	0.00063	CcSEcCtD
Vigabatrin—Conjunctivitis—Methotrexate—systemic scleroderma	0.000627	0.000627	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000627	0.000627	CcSEcCtD
Vigabatrin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000621	0.000621	CcSEcCtD
Vigabatrin—Pain—Mycophenolate mofetil—systemic scleroderma	0.000621	0.000621	CcSEcCtD
Vigabatrin—Vomiting—Leflunomide—systemic scleroderma	0.000614	0.000614	CcSEcCtD
Vigabatrin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000611	0.000611	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.00061	0.00061	CcSEcCtD
Vigabatrin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000609	0.000609	CcSEcCtD
Vigabatrin—Rash—Leflunomide—systemic scleroderma	0.000609	0.000609	CcSEcCtD
Vigabatrin—Dermatitis—Leflunomide—systemic scleroderma	0.000608	0.000608	CcSEcCtD
Vigabatrin—Mental disorder—Prednisone—systemic scleroderma	0.000607	0.000607	CcSEcCtD
Vigabatrin—Nausea—Azathioprine—systemic scleroderma	0.000607	0.000607	CcSEcCtD
Vigabatrin—Headache—Leflunomide—systemic scleroderma	0.000605	0.000605	CcSEcCtD
Vigabatrin—Malnutrition—Prednisone—systemic scleroderma	0.000604	0.000604	CcSEcCtD
Vigabatrin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000599	0.000599	CcSEcCtD
Vigabatrin—Asthenia—Lisinopril—systemic scleroderma	0.000595	0.000595	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000594	0.000594	CcSEcCtD
Vigabatrin—Pruritus—Lisinopril—systemic scleroderma	0.000587	0.000587	CcSEcCtD
Vigabatrin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000585	0.000585	CcSEcCtD
Vigabatrin—Rash—Mycophenolic acid—systemic scleroderma	0.000581	0.000581	CcSEcCtD
Vigabatrin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00058	0.00058	CcSEcCtD
Vigabatrin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000577	0.000577	CcSEcCtD
Vigabatrin—Headache—Mycophenolic acid—systemic scleroderma	0.000577	0.000577	CcSEcCtD
Vigabatrin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000574	0.000574	CcSEcCtD
Vigabatrin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000574	0.000574	CcSEcCtD
Vigabatrin—Nausea—Leflunomide—systemic scleroderma	0.000573	0.000573	CcSEcCtD
Vigabatrin—Vision blurred—Prednisone—systemic scleroderma	0.000569	0.000569	CcSEcCtD
Vigabatrin—Diarrhoea—Lisinopril—systemic scleroderma	0.000567	0.000567	CcSEcCtD
Vigabatrin—Ill-defined disorder—Prednisone—systemic scleroderma	0.00056	0.00056	CcSEcCtD
Vigabatrin—Visual impairment—Methotrexate—systemic scleroderma	0.000558	0.000558	CcSEcCtD
Vigabatrin—Anaemia—Prednisone—systemic scleroderma	0.000558	0.000558	CcSEcCtD
Vigabatrin—Agitation—Prednisone—systemic scleroderma	0.000555	0.000555	CcSEcCtD
Vigabatrin—Angioedema—Prednisone—systemic scleroderma	0.000552	0.000552	CcSEcCtD
Vigabatrin—Dizziness—Lisinopril—systemic scleroderma	0.000548	0.000548	CcSEcCtD
Vigabatrin—Erythema multiforme—Methotrexate—systemic scleroderma	0.000548	0.000548	CcSEcCtD
Vigabatrin—Nausea—Mycophenolic acid—systemic scleroderma	0.000547	0.000547	CcSEcCtD
Vigabatrin—Malaise—Prednisone—systemic scleroderma	0.000544	0.000544	CcSEcCtD
Vigabatrin—Vertigo—Prednisone—systemic scleroderma	0.000542	0.000542	CcSEcCtD
Vigabatrin—Eye disorder—Methotrexate—systemic scleroderma	0.000542	0.000542	CcSEcCtD
Vigabatrin—Tinnitus—Methotrexate—systemic scleroderma	0.00054	0.00054	CcSEcCtD
Vigabatrin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000535	0.000535	CcSEcCtD
Vigabatrin—Vomiting—Lisinopril—systemic scleroderma	0.000527	0.000527	CcSEcCtD
Vigabatrin—Rash—Lisinopril—systemic scleroderma	0.000523	0.000523	CcSEcCtD
Vigabatrin—Convulsion—Prednisone—systemic scleroderma	0.000523	0.000523	CcSEcCtD
Vigabatrin—Dermatitis—Lisinopril—systemic scleroderma	0.000522	0.000522	CcSEcCtD
Vigabatrin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000521	0.000521	CcSEcCtD
Vigabatrin—Headache—Lisinopril—systemic scleroderma	0.00052	0.00052	CcSEcCtD
Vigabatrin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000514	0.000514	CcSEcCtD
Vigabatrin—Myalgia—Prednisone—systemic scleroderma	0.000514	0.000514	CcSEcCtD
Vigabatrin—Arthralgia—Prednisone—systemic scleroderma	0.000514	0.000514	CcSEcCtD
Vigabatrin—Anxiety—Prednisone—systemic scleroderma	0.000512	0.000512	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00051	0.00051	CcSEcCtD
Vigabatrin—Discomfort—Prednisone—systemic scleroderma	0.000508	0.000508	CcSEcCtD
Vigabatrin—Mental disorder—Methotrexate—systemic scleroderma	0.000508	0.000508	CcSEcCtD
Vigabatrin—Malnutrition—Methotrexate—systemic scleroderma	0.000504	0.000504	CcSEcCtD
Vigabatrin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000497	0.000497	CcSEcCtD
Vigabatrin—Nausea—Lisinopril—systemic scleroderma	0.000493	0.000493	CcSEcCtD
Vigabatrin—Oedema—Prednisone—systemic scleroderma	0.000493	0.000493	CcSEcCtD
Vigabatrin—Infection—Prednisone—systemic scleroderma	0.000489	0.000489	CcSEcCtD
Vigabatrin—Back pain—Methotrexate—systemic scleroderma	0.000488	0.000488	CcSEcCtD
Vigabatrin—Nervous system disorder—Prednisone—systemic scleroderma	0.000483	0.000483	CcSEcCtD
Vigabatrin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000481	0.000481	CcSEcCtD
Vigabatrin—Skin disorder—Prednisone—systemic scleroderma	0.000478	0.000478	CcSEcCtD
Vigabatrin—Vision blurred—Methotrexate—systemic scleroderma	0.000475	0.000475	CcSEcCtD
Vigabatrin—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000468	0.000468	CcSEcCtD
Vigabatrin—Anaemia—Methotrexate—systemic scleroderma	0.000466	0.000466	CcSEcCtD
Vigabatrin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000462	0.000462	CcSEcCtD
Vigabatrin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000458	0.000458	CcSEcCtD
Vigabatrin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000458	0.000458	CcSEcCtD
Vigabatrin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000455	0.000455	CcSEcCtD
Vigabatrin—Malaise—Methotrexate—systemic scleroderma	0.000455	0.000455	CcSEcCtD
Vigabatrin—Vertigo—Methotrexate—systemic scleroderma	0.000453	0.000453	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000449	0.000449	CcSEcCtD
Vigabatrin—Insomnia—Prednisone—systemic scleroderma	0.000446	0.000446	CcSEcCtD
Vigabatrin—Paraesthesia—Prednisone—systemic scleroderma	0.000442	0.000442	CcSEcCtD
Vigabatrin—Cough—Methotrexate—systemic scleroderma	0.00044	0.00044	CcSEcCtD
Vigabatrin—Convulsion—Methotrexate—systemic scleroderma	0.000437	0.000437	CcSEcCtD
Vigabatrin—Dyspepsia—Prednisone—systemic scleroderma	0.000434	0.000434	CcSEcCtD
Vigabatrin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000432	0.000432	CcSEcCtD
Vigabatrin—Chest pain—Methotrexate—systemic scleroderma	0.000429	0.000429	CcSEcCtD
Vigabatrin—Myalgia—Methotrexate—systemic scleroderma	0.000429	0.000429	CcSEcCtD
Vigabatrin—Arthralgia—Methotrexate—systemic scleroderma	0.000429	0.000429	CcSEcCtD
Vigabatrin—Decreased appetite—Prednisone—systemic scleroderma	0.000428	0.000428	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000426	0.000426	CcSEcCtD
Vigabatrin—Fatigue—Prednisone—systemic scleroderma	0.000425	0.000425	CcSEcCtD
Vigabatrin—Discomfort—Methotrexate—systemic scleroderma	0.000424	0.000424	CcSEcCtD
Vigabatrin—Constipation—Prednisone—systemic scleroderma	0.000421	0.000421	CcSEcCtD
Vigabatrin—Confusional state—Methotrexate—systemic scleroderma	0.000415	0.000415	CcSEcCtD
Vigabatrin—Infection—Methotrexate—systemic scleroderma	0.000409	0.000409	CcSEcCtD
Vigabatrin—Feeling abnormal—Prednisone—systemic scleroderma	0.000406	0.000406	CcSEcCtD
Vigabatrin—Nervous system disorder—Methotrexate—systemic scleroderma	0.000404	0.000404	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000403	0.000403	CcSEcCtD
Vigabatrin—Skin disorder—Methotrexate—systemic scleroderma	0.0004	0.0004	CcSEcCtD
Vigabatrin—Urticaria—Prednisone—systemic scleroderma	0.000391	0.000391	CcSEcCtD
Vigabatrin—Body temperature increased—Prednisone—systemic scleroderma	0.000389	0.000389	CcSEcCtD
Vigabatrin—Abdominal pain—Prednisone—systemic scleroderma	0.000389	0.000389	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000375	0.000375	CcSEcCtD
Vigabatrin—Insomnia—Methotrexate—systemic scleroderma	0.000372	0.000372	CcSEcCtD
Vigabatrin—Paraesthesia—Methotrexate—systemic scleroderma	0.00037	0.00037	CcSEcCtD
Vigabatrin—Somnolence—Methotrexate—systemic scleroderma	0.000366	0.000366	CcSEcCtD
Vigabatrin—Hypersensitivity—Prednisone—systemic scleroderma	0.000363	0.000363	CcSEcCtD
Vigabatrin—Dyspepsia—Methotrexate—systemic scleroderma	0.000362	0.000362	CcSEcCtD
Vigabatrin—Decreased appetite—Methotrexate—systemic scleroderma	0.000358	0.000358	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000355	0.000355	CcSEcCtD
Vigabatrin—Fatigue—Methotrexate—systemic scleroderma	0.000355	0.000355	CcSEcCtD
Vigabatrin—Asthenia—Prednisone—systemic scleroderma	0.000353	0.000353	CcSEcCtD
Vigabatrin—Pain—Methotrexate—systemic scleroderma	0.000352	0.000352	CcSEcCtD
Vigabatrin—Pruritus—Prednisone—systemic scleroderma	0.000349	0.000349	CcSEcCtD
Vigabatrin—Feeling abnormal—Methotrexate—systemic scleroderma	0.000339	0.000339	CcSEcCtD
Vigabatrin—Diarrhoea—Prednisone—systemic scleroderma	0.000337	0.000337	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000337	0.000337	CcSEcCtD
Vigabatrin—Urticaria—Methotrexate—systemic scleroderma	0.000327	0.000327	CcSEcCtD
Vigabatrin—Dizziness—Prednisone—systemic scleroderma	0.000326	0.000326	CcSEcCtD
Vigabatrin—Abdominal pain—Methotrexate—systemic scleroderma	0.000325	0.000325	CcSEcCtD
Vigabatrin—Body temperature increased—Methotrexate—systemic scleroderma	0.000325	0.000325	CcSEcCtD
Vigabatrin—Vomiting—Prednisone—systemic scleroderma	0.000313	0.000313	CcSEcCtD
Vigabatrin—Rash—Prednisone—systemic scleroderma	0.000311	0.000311	CcSEcCtD
Vigabatrin—Dermatitis—Prednisone—systemic scleroderma	0.00031	0.00031	CcSEcCtD
Vigabatrin—Headache—Prednisone—systemic scleroderma	0.000309	0.000309	CcSEcCtD
Vigabatrin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000303	0.000303	CcSEcCtD
Vigabatrin—Asthenia—Methotrexate—systemic scleroderma	0.000295	0.000295	CcSEcCtD
Vigabatrin—Nausea—Prednisone—systemic scleroderma	0.000293	0.000293	CcSEcCtD
Vigabatrin—Pruritus—Methotrexate—systemic scleroderma	0.000291	0.000291	CcSEcCtD
Vigabatrin—Diarrhoea—Methotrexate—systemic scleroderma	0.000282	0.000282	CcSEcCtD
Vigabatrin—Dizziness—Methotrexate—systemic scleroderma	0.000272	0.000272	CcSEcCtD
Vigabatrin—Vomiting—Methotrexate—systemic scleroderma	0.000262	0.000262	CcSEcCtD
Vigabatrin—Rash—Methotrexate—systemic scleroderma	0.00026	0.00026	CcSEcCtD
Vigabatrin—Dermatitis—Methotrexate—systemic scleroderma	0.000259	0.000259	CcSEcCtD
Vigabatrin—Headache—Methotrexate—systemic scleroderma	0.000258	0.000258	CcSEcCtD
Vigabatrin—Nausea—Methotrexate—systemic scleroderma	0.000245	0.000245	CcSEcCtD
